Healx
Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD256—385m (Dealroom.co estimates Aug 2024.)
Company register number 09018507
Cambridge England (HQ)
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | <1m | <1m | <1m | <1m | <1m |
| % growth | 103 % | 75 % | 14 % | 30 % | 29 % | (17 %) | (6 %) |
| EBITDA | (<1m) | (2.7m) | (6.5m) | (10.6m) | (22.0m) | (33.5m) | - |
| % EBITDA margin | (925 %) | (1429 %) | (3023 %) | (3770 %) | (6100 %) | (11171 %) | - |
| Profit | (<1m) | (3.1m) | (5.4m) | (9.7m) | (18.8m) | (30.9m) | - |
| % profit margin | (815 %) | (1653 %) | (2532 %) | (3451 %) | (5226 %) | (10294 %) | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | N/A | Spinout | |
N/A | - | ||
* | £1.5m | Series A | |
$10.0m | Series A | ||
$56.0m | Series B | ||
N/A | Support Program | ||
$21.9m Valuation: $280m 848.5x EV/LTM Revenues -7.6x EV/LTM EBITDA | Late VC | ||
* | $47.0m | Series C | |
| Total Funding | CAD187m | ||
Related Content
Recent News about Healx
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.